JACKSON SQUARE CAPITAL, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1812178 SAN FRANCISCO, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$546,813

-$3,171,638 QoQ

Shares Held

9,490

-84.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#1,480

of 2,506 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JACKSON SQUARE CAPITAL, LLC holds $34,281,243 across 7 Drug Manufacturers - General names. BMY ranks #6 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	18,872	$22,635,644
2	MRK	Merck & Co., Inc.	34,686	$4,457,151
3	ABBV	AbbVie Inc.	14,566	$3,665,388
4	JNJ	Johnson & Johnson	7,767	$1,972,584
5	NVS	Novartis AG	3,643	$570,930
6	BMY	Bristol Myers Squibb Co This page	9,490	$546,813
7	AMGN	Amgen Inc	1,195	$432,733

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$546,813	9,490	-84.5%	Shares	Sole	2026-07-21
2026-03-31	$3,718,451	61,310	+145.7%	Shares	Sole	2026-04-13
2025-03-31	$1,521,883	24,953	+3.1%	Shares	Sole	2025-04-16
2024-12-31	$1,369,091	24,206	+204.4%	Shares	Sole	2025-01-15
2022-06-30	$612,304	7,952	0.0%	Shares	Sole	2022-07-25
2022-03-31	$580,734	7,952	+79.7%	Shares	Sole	2022-04-20
2021-12-31	$275,961	4,426	-90.0%	Shares	Sole	2022-01-19
2021-09-30	$2,610,284	44,115	-1.4%	Shares	Sole	2021-10-28
2021-06-30	$2,989,927	44,746	-0.2%	Shares	Sole	2021-07-20
2021-03-31	$2,831,633	44,854	-5.0%	Shares	Sole	2021-05-18
2020-12-31	$2,928,560	47,212	-1.8%	Shares	Sole	2021-03-05
2020-09-30	$2,897,356	48,057	-1.6%	Shares	Sole	2020-11-17
2020-06-30	$2,871,909	48,842	+28.0%	Shares	Sole	2020-08-18
2020-03-31	$2,126,982	38,159	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.